What was MabCure’s price range in the past 12 months?
MabCure lowest stock price was $0.00 and its highest was $0.02 in the past 12 months.
What is MabCure’s market cap?
MabCure’s market cap is $32.18K.
When is MabCure’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is MabCure overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does MabCure pay dividends?
MabCure does not currently pay dividends.
What is MabCure’s EPS estimate?
MabCure’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MabCure have?
MabCure has 64,364,000 shares outstanding.
Which hedge fund is a major shareholder of MabCure?
Currently, no hedge funds are holding shares in MBCI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MabCure
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.